Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2026)
Fulgent Genetics (FLGT) posted Income from Non-Controlling Interests of -$448000.0 for Q1 2026, down 93.1% sequentially from -$232000.0 in Q4 2025, and down 21.41% YoY from -$570041.4 in Q1 2025.
Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Fulgent Genetics (FLGT) has 6 years of Income from Non-Controlling Interests data on file, last reported at -$448000.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 21.41% year-over-year to -$448000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 9.12% YoY) and the FY2025 annual result came in at -$1.1 million, down 0.54% from the prior year.
- Income from Non-Controlling Interests retreated to -$448000.0 in Q1 2026 per FLGT's latest filing, from -$232000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$46000.0 in Q3 2024, with the low at -$6.2 million in Q4 2023.
- Average Income from Non-Controlling Interests over 5 years is -$680705.9, with a median of -$369000.0 recorded in 2025.
- Year-over-year, Income from Non-Controlling Interests sank 2434.84% in 2023 and surged 95.12% in 2024.
- Fulgent Genetics' Income from Non-Controlling Interests stood at -$244000.0 in 2022, then slumped by 2434.84% to -$6.2 million in 2023, then surged by 95.12% to -$302000.0 in 2024, then climbed by 23.18% to -$232000.0 in 2025, then slumped by 93.1% to -$448000.0 in 2026.
- Business Quant data shows FLGT's Income from Non-Controlling Interests at -$448000.0 in Q1 2026, -$232000.0 in Q4 2025, and -$218000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Fulgent Genetics | 642.94 Mn | 360.99 Mn | 21.49 Mn | -448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -448,000.00 |
| Dec 31, 2025 | -232,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | -299,000.00 |
| Mar 31, 2025 | -369,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Sep 30, 2024 | -46,000.00 |
| Jun 30, 2024 | -380,000.00 |
| Mar 31, 2024 | -384,000.00 |
| Dec 31, 2023 | -6.19 Mn |
| Sep 30, 2023 | -359,000.00 |
| Jun 30, 2023 | -361,000.00 |
| Mar 31, 2023 | -509,000.00 |
| Dec 31, 2022 | -244,000.00 |
| Sep 30, 2022 | -376,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -422,000.00 |
| Dec 31, 2021 | -662,000.00 |
| Sep 30, 2021 | -298,000.00 |
| Jun 30, 2021 | -165,000.00 |